Document Format Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
1 | CURRENT REPORT | ea0232201-8k_biomx.htm iXBRL | 8-K | 52111 |
2 | FORM OF PRE-FUNDED WARRANT | ea023220101ex4-1_biomx.htm | EX-4.1 | 108000 |
3 | FORM OF PRIVATE PRE-FUNDED WARRANT | ea023220101ex4-2_biomx.htm | EX-4.2 | 103295 |
4 | FORM OF COMMON WARRANT | ea023220101ex4-3_biomx.htm | EX-4.3 | 113293 |
5 | FORM OF NEW WARRANT | ea023220101ex4-4_biomx.htm | EX-4.4 | 117341 |
6 | FORM OF AMENDED AND RESTATED WARRANT | ea023220101ex4-5_biomx.htm | EX-4.5 | 107434 |
7 | OPINION OF HAYNES AND BOONE, LLP | ea023220101ex5-1_biomx.htm | EX-5.1 | 14629 |
8 | FORM OF SECURITIES PURCHASE AGREEMENT DATED FEBRUARY 25, 2025, BETWEEN BIOMX INC | ea023220101ex10-1_biomx.htm | EX-10.1 | 332194 |
9 | FORM OF REGISTRATION RIGHTS AGREEMENT DATED FEBRUARY 25, 2025, BETWEEN BIOMX INC | ea023220101ex10-2_biomx.htm | EX-10.2 | 170013 |
10 | WARRANT EXERCISE AND RELOAD AGREEMENT DATED FEBRUARY 25, 2025, BETWEEN BIOMX INC | ea023220101ex10-3_biomx.htm | EX-10.3 | 70279 |
11 | PLACEMENT AGENCY AGREEMENT DATED FEBRUARY 25, 2025, BETWEEN BIOMX INC. AND LAIDL | ea023220101ex10-4_biomx.htm | EX-10.4 | 85222 |
12 | PRESS RELEASE ISSUED FEBRUARY 26, 2025 | ea023220101ex99-1_biomx.htm | EX-99.1 | 22192 |
13 | INVESTOR PRESENTATION DECK DATED FEBRUARY 26, 2025 | ea023220101ex99-2_biomx.htm | EX-99.2 | 56881 |
14 | GRAPHIC | ex5-1_001.jpg | GRAPHIC | 11068 |
15 | GRAPHIC | ex5-1_002.jpg | GRAPHIC | 3856 |
16 | GRAPHIC | ex99-2_001.jpg | GRAPHIC | 802570 |
17 | GRAPHIC | ex99-2_002.jpg | GRAPHIC | 1157440 |
18 | GRAPHIC | ex99-2_003.jpg | GRAPHIC | 477192 |
19 | GRAPHIC | ex99-2_004.jpg | GRAPHIC | 955610 |
20 | GRAPHIC | ex99-2_005.jpg | GRAPHIC | 371579 |
21 | GRAPHIC | ex99-2_006.jpg | GRAPHIC | 740687 |
22 | GRAPHIC | ex99-2_007.jpg | GRAPHIC | 575375 |
23 | GRAPHIC | ex99-2_008.jpg | GRAPHIC | 495082 |
24 | GRAPHIC | ex99-2_009.jpg | GRAPHIC | 579686 |
25 | GRAPHIC | ex99-2_010.jpg | GRAPHIC | 583426 |
26 | GRAPHIC | ex99-2_011.jpg | GRAPHIC | 589441 |
27 | GRAPHIC | ex99-2_012.jpg | GRAPHIC | 434208 |
28 | GRAPHIC | ex99-2_013.jpg | GRAPHIC | 424986 |
29 | GRAPHIC | ex99-2_014.jpg | GRAPHIC | 766035 |
30 | GRAPHIC | ex99-2_015.jpg | GRAPHIC | 325978 |
31 | GRAPHIC | ex99-2_016.jpg | GRAPHIC | 473099 |
32 | GRAPHIC | ex99-2_017.jpg | GRAPHIC | 530626 |
33 | GRAPHIC | ex99-2_018.jpg | GRAPHIC | 464190 |
34 | GRAPHIC | ex99-2_019.jpg | GRAPHIC | 717015 |
35 | GRAPHIC | ex99-2_020.jpg | GRAPHIC | 602707 |
36 | GRAPHIC | ex99-2_021.jpg | GRAPHIC | 502200 |
37 | GRAPHIC | ex99-2_022.jpg | GRAPHIC | 517792 |
38 | GRAPHIC | ex99-2_023.jpg | GRAPHIC | 491492 |
39 | GRAPHIC | ex99-2_024.jpg | GRAPHIC | 500618 |
40 | GRAPHIC | ex99-2_025.jpg | GRAPHIC | 547920 |
41 | GRAPHIC | ex99-2_026.jpg | GRAPHIC | 491669 |
42 | GRAPHIC | ex99-2_027.jpg | GRAPHIC | 559539 |
43 | GRAPHIC | ex99-2_028.jpg | GRAPHIC | 89020 |
44 | GRAPHIC | ex99-2_029.jpg | GRAPHIC | 484059 |
45 | GRAPHIC | ex99-2_030.jpg | GRAPHIC | 446326 |
46 | GRAPHIC | ex99-2_031.jpg | GRAPHIC | 847689 |
47 | GRAPHIC | ex99-2_032.jpg | GRAPHIC | 803058 |
48 | GRAPHIC | ex99-2_033.jpg | GRAPHIC | 1336463 |
Complete submission text file | 0001213900-25-017728.txt | 28994632 |
Data Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
49 | XBRL SCHEMA FILE | phge-20250225.xsd | EX-101.SCH | 3006 |
50 | XBRL LABEL FILE | phge-20250225_lab.xml | EX-101.LAB | 34240 |
51 | XBRL PRESENTATION FILE | phge-20250225_pre.xml | EX-101.PRE | 22353 |
62 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0232201-8k_biomx_htm.xml | XML | 3648 |
EIN.: 823364020 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 25674399
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)